How BioMarin's $270 Million Takeover Led This Dollar Stock To A Triple-Digit Gain
How BioMarin's $270 Million Takeover Led This Dollar Stock To A Triple-Digit Gain · Investor's Business Daily

In This Article:

BioMarin said Friday it would spend $270 million to acquire Inozyme Pharma, sending shares of the latter skyrocketing by triple digits.